Jump Financial, LLC Organogenesis Holdings Inc. Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	BUY	$1.97 - $4.21 $89,099 - $190,409	45,228 New	45,228 $184,000
Q4 2023 Feb 07, 2024	BUY	$1.97 - $4.21 $89,099 - $190,409	45,228 New	45,228 $184,000
Q4 2022 Feb 13, 2023	SELL	$2.48 - $3.43 $159,471 - $220,559	-64,303 Reduced 44.84%	79,111 $212,000
Q3 2022 Nov 07, 2022	BUY	$3.14 - $6.43 $337,267 - $690,646	107,410 Added 298.33%	143,414 $464,000
Q2 2022 Aug 09, 2022	BUY	$4.74 - $8.15 $170,658 - $293,432	36,004 New	36,004 $175,000
Q1 2022 May 12, 2022	SELL	$6.47 - $9.57 $212,863 - $314,853	-32,900 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$9.02 - $13.5 $296,758 - $444,150	32,900 New	32,900 $304,000
Q3 2021 Nov 12, 2021	SELL	$13.71 - $17.18 $2.24 Million - $2.81 Million	-163,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $1.85 Million - $2.89 Million	124,200 Added 314.43%	163,700 $2.72 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $97,489 - $280,098	13,300 Added 50.76%	39,500 $720,000
Q4 2020 Feb 12, 2021	BUY	$3.63 - $7.53 $95,106 - $197,286	26,200 New	26,200 $197,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $437M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.